We are committed to transforming cancer treatment by unleashing the full power of highly potent immunotherapies precisely in the tumors. Learn more about Xilio Therapeutics.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Total raised: $195.5M
Founded date: 2020
Investors 12
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.02.2021 | Series C | $95M | - |
| 04.03.2020 | Series B | $100.5M | SV Health ... |
Mentions in press and media 17
| Date | Title | Description | Source |
| 28.03.2024 | Xilio Therapeutics Announces $11.3 Million Private Placement... | - | globenewsw... |
| 01.10.2021 | Solid tumor biotech Xilio Therapeutics files for a $100 mill... | - | fprimecapi... |
| 25.02.2021 | Xilio Therapeutics Raises $95 Million in Series C Financing ... | • Deal led by Rock Springs Capital and joined by Bain Capital Life Sciences, Deerfield Management, R... | m-ventures... |
| 25.02.2021 | Xilio Therapeutics Raises $95M in Series C | WALTHAM, MA, Xilio Therapeutics has closed a $95 million Series C financing led by Rock Springs Ca... | vcnewsdail... |
| 24.02.2021 | Xilio raises $95M to take twists on Yervoy and IL-2 into cli... | Xilio Therapeutics has raised $95 million to take IL-2 and CTLA-4 immunotherapies into clinical tria... | fiercebiot... |
| 24.02.2021 | Xilio raises $95M to take twists on Yervoy and IL-2 into cli... | Xilio Therapeutics has raised $95 million to take IL-2 and CTLA-4 immunotherapies into clinical tria... | fiercebiot... |
| 24.02.2021 | Xilio Therapeutics Raises $95 Million in Series C Financing ... | February 24, 2021 06:00 AM Eastern Standard Time | svhealthin... |
| 24.02.2021 | Xilio Therapeutics Raises $95 Million in Series C | WALTHAM, Mass.--(BUSINESS WIRE)--Xilio Therapeutics, a biotechnology company developing potent, tumo... | citybizlis... |
| 10.11.2020 | Xilio Therapeutics to Present Data on Tumor-Selective Immuno... | WALTHAM, Mass.--(BUSINESS WIRE)--Xilio Therapeutics, a biotechnology company developing potent, tumo... | svhealthin... |
| 27.04.2020 | Xilio Therapeutics Appoints Martin H. Huber, M.D. as Chief M... | WALTHAM, Mass.--(BUSINESS WIRE)--Xilio Therapeutics, a company developing potent, tumor-selective im... | svhealthin... |
Show more